艰难梭菌感染的微生物组治疗。

IF 4.1 3区医学 Q1 IMMUNOLOGY

Infectious disease clinics of North America Pub Date : 2025-08-11 DOI:10.1016/j.idc.2025.07.007

Christine W Lucky, Brendan J Kelly, Jennie H Kwon, Michael H Woodworth, Rachel L Medernach

{"title":"艰难梭菌感染的微生物组治疗。","authors":"Christine W Lucky, Brendan J Kelly, Jennie H Kwon, Michael H Woodworth, Rachel L Medernach","doi":"10.1016/j.idc.2025.07.007","DOIUrl":null,"url":null,"abstract":"Microbiota-based therapies are used increasingly for the treatment and prevention of Clostridioides difficile infection (CDI), particularly in cases of recurrent CDI (rCDI). This review discusses the different types of microbiota-based therapies, including fecal microbiota transplant, fecal microbiota products, and live biotherapeutic products. The authors present efficacy data regarding clinical use in rCDI and highlight the unique aspects of each product.","PeriodicalId":13562,"journal":{"name":"Infectious disease clinics of North America","volume":" ","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12435572/pdf/","citationCount":"0","resultStr":"{\"title\":\"Microbiome Therapeutics for Clostridioides difficile Infection.\",\"authors\":\"Christine W Lucky, Brendan J Kelly, Jennie H Kwon, Michael H Woodworth, Rachel L Medernach\",\"doi\":\"10.1016/j.idc.2025.07.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Microbiota-based therapies are used increasingly for the treatment and prevention of Clostridioides difficile infection (CDI), particularly in cases of recurrent CDI (rCDI). This review discusses the different types of microbiota-based therapies, including fecal microbiota transplant, fecal microbiota products, and live biotherapeutic products. The authors present efficacy data regarding clinical use in rCDI and highlight the unique aspects of each product.\",\"PeriodicalId\":13562,\"journal\":{\"name\":\"Infectious disease clinics of North America\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-08-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12435572/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infectious disease clinics of North America\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.idc.2025.07.007\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious disease clinics of North America","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.idc.2025.07.007","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

基于微生物群的治疗越来越多地用于治疗和预防艰难梭菌感染（CDI），特别是复发性CDI （rCDI）。本文综述了不同类型的基于微生物群的治疗方法，包括粪便微生物群移植、粪便微生物群产品和活体生物治疗产品。作者介绍了rCDI临床使用的疗效数据，并强调了每种产品的独特之处。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Microbiome Therapeutics for Clostridioides difficile Infection.

Microbiota-based therapies are used increasingly for the treatment and prevention of Clostridioides difficile infection (CDI), particularly in cases of recurrent CDI (rCDI). This review discusses the different types of microbiota-based therapies, including fecal microbiota transplant, fecal microbiota products, and live biotherapeutic products. The authors present efficacy data regarding clinical use in rCDI and highlight the unique aspects of each product.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Infectious disease clinics of North America 医学-传染病学

CiteScore

8.30

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Infectious Disease Clinics of North America updates you on the latest trends in the clinical diagnosis and management of patients with infectious diseases, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in infectious disease, including clinical microbiology, compromised host infections, gastrointestinal infections, global health, hepatitis, HIV/AIDS, hospital-acquired infections, travel medicine, infection control, bacterial infections, sexually transmitted diseases, urinary tract infections, and viral infections.